中财网 中财网股票行情
昭衍新药(603127)财务分析指标    年份：
截止日期2026-09-302026-06-302026-03-312025-12-312025-09-30
营业总收入(万元)118790.6070381.9031613.50165762.4398496.15
营业收入(万元)118790.6070381.9031613.50165762.4398496.15
营业总成本(万元)112845.2371200.8633423.03166321.46109943.77
营业成本(万元)86182.9353659.8225137.18131431.2277268.14
净利润(万元)91252.8473456.8723177.6927855.337422.58
归属于母公司的净利润(万元)92968.7074751.7423835.6729784.108070.61
营业利润(万元)101825.8481530.0025591.9433799.119945.20
利润总额(万元)101815.8681524.3225605.5433749.339962.54
少数股东损益(万元)0.140.14-0.520.150.00
基本每股收益(元)1.25(元)1.00(元)0.32(元)0.40(元)0.11(元)
稀释每股收益(元)1.24(元)1.00(元)0.32(元)0.40(元)0.11(元)
非经常性损益(万元)--------5166.13
扣除非经常性损益后净利润(万元)88095.1469886.9721739.1331147.552904.47
总资产(万元)1134782.371082603.871003686.59968190.86953338.27
总负债(万元)218203.87185069.26147974.30135655.75141236.05
归属于母公司股东权益合计(万元)916578.50897497.36855675.70832498.00812065.26
股东权益合计(万元)916578.50897534.61855712.29832535.12812102.22
实收资本(股本)(万元)74934.8274934.8274934.8274947.7374947.73
资本公积(万元)522337.62520411.00523360.78523766.59523766.59
未分配利润(万元)321057.09302840.14260878.15237042.49215328.99
经营活动产生的现金流量净额(万元)85328.1945721.3912761.1244456.6726639.11
经营活动现金流入小计(万元)204803.58125650.5055684.79183212.73132347.20
经营活动现金流出小计(万元)119475.3979929.1142923.67138756.06105708.08
投资活动产生的现金流量净额(万元)-115937.76-49246.49-4218.67-41919.29-26472.26
投资活动现金流入小计(万元)336273.64250559.93143709.68237051.18196698.35
投资活动现金流出小计(万元)452211.40299806.42147928.35278970.47223170.61
筹资活动产生的现金流量净额(万元)-5460.57-3562.61-544.75-6698.41-5898.85
筹资活动现金流入小计(万元)5022.155022.15------
筹资活动现金流出小计(万元)10482.728584.76544.756698.415898.85
期末现金及现金等价物余额(万元)53078.3282393.5498308.4991185.4390206.05
最后修改日期2026-10-282026-08-282026-05-062026-03-302025-11-01
↑返回页顶↑

转至昭衍新药（603127）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。